|4Mar 18, 8:06 PM ET

ANNETT WILLIAM 4

4 · OncoCyte Corp · Filed Mar 18, 2019

Insider Transaction Report

Form 4
Period: 2019-03-14
ANNETT WILLIAM
DirectorPresident and CEO
Transactions
  • Award

    Option to Purchase Common Stock

    2019-03-14+390,000390,000 total
    Exercise: $3.52Exp: 2029-03-13Common Stock (390,000 underlying)
Footnotes (1)
  • [F1]One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on March 14, 2019 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION